Improvement of oxidative and metabolic parameters by cellfood administration in patients affected by neurodegenerative diseases on chelation treatment

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Fulgenzi, Alessandro ^a   Giuseppe, Rachele De ^b   Bamonti, Fabrizia ^b   Ferrero, Maria Elena ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CALCIUM DISODIUM ETHYLENEDIAMINETETRAACETIC ACID; CHELATING AGENT; CYANOCOBALAMIN; EDETIC ACID; EDETIC ACID DERIVATIVE; FOLIC ACID; GLUTATHIONE; HEAVY METAL; HOMOCYSTEINE; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; AMINO ACID; CELLFOOD; CHOLESTEROL; ENZYME; LIPOPROTEIN; MINERAL; SULFATE;

ADULT; ALZHEIMER DISEASE; AMINO ACID METABOLISM; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD ANALYSIS; BODY BURDEN; CELLFOOD; CHELATION THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOOD; HUMAN; MALE; METABOLIC PARAMETERS; MULTIPLE SCLEROSIS; OXIDATION; PARKINSON DISEASE; PILOT STUDY; PROSPECTIVE STUDY; BLOOD; METABOLISM; NEURODEGENERATIVE DISEASES;

AMINO ACIDS; ANTIOXIDANTS; CHELATING AGENTS; CHOLESTEROL; ENZYMES; GLUTATHIONE; HUMANS; LIPOPROTEINS; MINERALS; NEURODEGENERATIVE DISEASES; PILOT PROJECTS; PROSPECTIVE STUDIES; REACTIVE OXYGEN SPECIES; SULFATES;

EID: 84904625024     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/281510     Document Type: Article

References (48)

1. von Geldern G., Mowry E. M., The influence of nutritional factors on the prognosis of multiple sclerosis. Nature Reviews Neurology 2012 8 12 678 689 10.1038/nrneurol.2012.194 2-s2.0-84870792480
2. Limousin N., Blasco H., Corcia P., Gordon P. H., De Toffol B., Andres C., Praline J., Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS. Journal of the Neurological Sciences 2010 297 1-2 36 39 10.1016/j.jns.2010.06.028 2-s2.0-77956676420
3. Mi W., van Wijk N., Cansev M., Sijben J. W. C., Kamphuis P. J. G. H., Nutritional approaches in the risk reduction and management of Alzheimer's disease. Nutrition 2013 29 9 1080 1089 10.1016/j.nut.2013.01.024 2-s2.0-84881376185
4. Guerra-Araiza C., Álvarez-Mejía A. L., Sánchez- Torres S., Farfan-García E., Mondragón-Lozano R., Pinto-Almazán R., Salgado-Ceballos H., Effect of natural exogenous antioxidants on aging and on neurodegenerative diseases. Free Radical Research 2013 47 6-7 451 462 10.3109/10715762.2013.795649 2-s2.0-84878821688
5. Kouti L., Noroozian M., Akhondzadeh S., Abdollahi M., Javadi M. R., Faramarzi M. A., Mousavi S., Ghaeli P., Nitric oxide and peroxynitrite serum levels in Parkinson's disease: correlastion of oxidative stress and the severity of the disease. European Review for Medical and Pharmacological Sciences 2013 17 7 964 970 2-s2.0-84878607066
6. Ferreres F., Grosso C., Gil-Izquierdo A., Valentão P., Andrade P. B., Phenolic compounds from Jacaranda caroba (Vell.) A. DC.: approaches to neurodegenerative disorders. Food and Chemical Toxicology 2013 57 91 98 10.1016/j.fct.2013.03.012 2-s2.0-84876325398
7. Holmay M. J., Terpstra M., Coles L. D., Mishra U., Ahlskog M., Öz G., Cloyd J. C., Tuite P. J., N-acetylcysteine boosts brain and blood glutathione in gaucher and Parkinson diseases. Clinical Neuropharmacology 2013 36 4 103 106 10.1097/WNF.0b013e31829ae713 2-s2.0-84880828603
8. Kasote D. M., Hegde M. V., Katyare S. S., Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy. BioFactors 2013 39 4 392 406 10.1002/biof.1093 2-s2.0-84881667979
9. Edeas M., Weissig V., Targeting mitochondria: strategies, innovations and challenges: the future of medicine will come through mitochondria. Mitochondrion 2013 13 5 389 390 10.1016/j.mito.2013.03.009 2-s2.0-84882835674
10. Mao P., Manczak M., Shirendeb U. P., Reddy P. H., MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Biochimica et Biophysica Acta 2013 1832 12 2322 2331 10.1016/j.bbadis.2013.09.005
11. Ferrero E., Fulgenzi A., Belloni D., Foglieni C., Ferrero M. E., Cellfood improves respiratory metabolism of endothelial cells and inhibits hypoxia-induced rective oxygen species (ROS) generation. Journal of Physiology and Pharmacology 2011 62 3 287 293 2-s2.0-80355143539
12. Fulgenzi A., Zanella S. G., Mariani M. M., Vietti D., Ferrero M. E., A case of multiple sclerosis improvement following removal of heavy metal intoxication. BioMetals 2012 25 3 569 576 10.1007/s10534-012-9537-7 2-s2.0-84864917369
13. Lin-Tan D. T., Lin J. L., Yen T. H., Chen K. H., Huang Y. L., Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases. Nephrology Dialysis Transplantation 2007 22 10 2924 2931 10.1093/ndt/gfm342 2-s2.0-36049017433 (Pubitemid 350093441)
14. Lin J., Lin-Tan D., Hsu K., Yu C., Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. The New England Journal of Medicine 2003 348 4 277 286 10.1056/NEJMoa021672 2-s2.0-0037461599 (Pubitemid 36119982)
15. Uttara B., Singh A. V., Zamboni P., Mahajan R. T., Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Current Neuropharmacology 2009 7 1 65 74 10.2174/157015909787602823 2-s2.0-65949121134
16. Presnell C. E., Bhatti G., Numan L. S., Lerche M., Alkhateeb S. K., Ghalib M., Shammaa M., Kavdia M., Computational insights into the role of glutathione in oxidative stress. Current Neurovascular Research 2013 10 2 185 194 10.2174/1567202611310020011 2-s2.0-84879802374
17. O'Sullivan C., Dev K. K., The structure and function of the S1P1 receptor. Trends in Pharmacological Sciences 2013 34 7 401 412 10.1016/j.tips.2013.05.002 2-s2.0-84879780889
18. Chiba K., Adachi K., Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis. Future Medicinal Chemistry 2012 4 6 771 781 10.4155/fmc.12.25 2-s2.0-84860238237
19. Roussel A. M., Hininger-Favier I., Waters R. S., Osman M., Fernholz K., Anderson R. A., EDTA chelation therapy, without added vitamin C, decreases oxidative DNA damage and lipid peroxidation. Alternative Medicine Review 2009 14 1 56 61 2-s2.0-65349114196
20. Benedetti S., Catalani S., Palma F., Canestrari F., The antioxidant protection of CELLFOOD against oxidative damage in vitro. Food and Chemical Toxicology 2011 49 9 2292 2298 10.1016/j.fct.2011.06.029 2-s2.0-79960836894
21. Pawlak K., Mysliwiec M., Pawlak D., Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio-are they real oxidative stress markers in dialyzed patients? Life Sciences 2013 92 4-5 253 258 10.1016/j.lfs.2012.12.002 2-s2.0-84873741599
22. Millan J., Pinto X., Munoz A., Zuniga M., Rubies-Prat J., Pallardo L. F., Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vascular Health and Risk Management 2009 5 757 765
23. Kovacic P., Somanathan R., Redox processes in neurodegenerative disease involving reactive oxygen species. Current Neuropharmacology 2012 10 4 289 302 10.2174/157015912804499429 2-s2.0-84874860528
24. Das L., Bhaumik E., Raychaudhuri U., Chakraborty R., Role of nutraceuticals in human health. Journal of Food Science and Technology 2012 49 2 173 183 10.1007/s13197-011-0269-4 2-s2.0-84862164586
25. Soory M., Nutritional antioxidants and their applications in cardiometabolic diseases. Infectious Disorders-Drug Targets 2012 12 5 388 401 10.2174/187152612804142233 2-s2.0-84872255925
26. Alvarez-Suarez J. M., Giampieri F., Battino M., Honey as a source of dietary antioxidants: structures, bioavailability and evidence of protective effects against human chronic diseases. Current Medicinal Chemistry 2013 20 5 621 638 10.2174/092986713804999358 2-s2.0-84877273439
27. Patrick L., Toxic metals and antioxidants: part II. The role of antioxidants in arsenic and cadmium toxicity. Alternative Medicine Review 2003 8 2 106 128 2-s2.0-0038349938 (Pubitemid 36676180)
28. De Nicoló S., Tarani L., Ceccanti M., Maldini M., Natella F., Vania A., Chaldakov G. N., Fiore M., Effects of olive polyphenols administration on nerve growth factor and brain-derived neurotrophic factor in the mouse brain. Nutrition 2013 29 4 681 687 10.1016/j.nut.2012.11.007 2-s2.0-84875330228
29. de Araújo D. P., De Sousa C. N., Araújo P. V. P., Behavioral and neurochemical effects of alpha-lipoic Acid in the model of Parkinson's disease induced by unilateral stereotaxic injection of 6-ohda in rat. Evidence-Based Complementary and Alternative Medicine 2013 2013 13 571378 10.1155/2013/571378
30. Cacciatore I., Cornacchia C., Fornasari E., A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation. ChemMedChem 2013 8 11 1818 1829 10.1002/cmdc.201300295
31. Goldschmidt R., Arce P. M., Khdour O. M., Collin V. C., Dey S., Jaruvangsanti J., Fash D. M., Hecht S. M., Effects of cytoprotective antioxidants on lymphocytes from representative mitochondrial neurodegenerative diseases. Bioorganic and Medicinal Chemistry 2013 21 4 969 978 10.1016/j.bmc.2012.11.051 2-s2.0-84873322437
32. Csont T., Sarkozy M., Szucs G., Szucs C., Barkanyi J., Bencsik P., Effect of a multivitamin preparation supplemented with phytosterol on serum lipids and infarct size in rats fed with normal and high cholesterol diet. Lipids in Health and Disease 2013 12 138 10.1186/1476-511X-12-138
33. Pantzaris M. C., Loukaides G. N., Ntzani E. E., Patrikios I. S., A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial. BMJ Open 2013 3 4 e002170 10.1136/bmjopen-2012-002170 2-s2.0-84877698744
34. Jin H., Kanthasamy A., Ghosh A., Anantharam V., Kalyanaraman B., Kanthasamy A. G., Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes. Biochimica et Biophysica Acta 2014 1842 8 1282 1294
35. de Oliveira J., Hort M. A., Moreira E. L. G., Glaser V., Ribeiro-do-Valle R. M., Prediger R. D., Farina M., Latini A., de Bem A. F., Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress. Neuroscience 2011 197 99 106 10.1016/j.neuroscience.2011. 09.009 2-s2.0-82855172098
36. Palavra F., Marado D., Mascarenhas-Melo F., Sereno J., Teixeira-Lemos E., Nunes C. C., Gonçalves G., Teixeira F., Reis F., New markers of early cardiovascular risk in multiple sclerosis patients: oxidized-LDL correlates with clinical staging. Disease Markers 2013 34 5 341 348 10.3233/DMA-130979 2-s2.0-84878866094
37. Kardys A., Weinstock-Guttman B., Dillon M., Masud M. W., Weinstock N., Mahfooz N., Lang J. K., Weinstock A., Lincoff N., Zivadinov R., Ramanathan M., Cholesterol affects retinal nerve fiber layer thickness in patients with multiple sclerosis with optic neuritis. European Journal of Neurology 2013 20 9 1264 1271 10.1111/ene.12162 2-s2.0-84881029434
38. Weinstock-Guttman B., Zivadinov R., Horakova D., Havrdova E., Qu J., Shyh G., Lakota E., O'Connor K., Badgett D., Tamaño-Blanco M., Tybova M., Hussein S., Bergsland N., Willis L., Krasensky J., Vaneckova M., Seidl Z., Ramanathan M., Lipid profiles are associated with lesion formation over 24 months in interferon- β treated patients following the first demyelinating event. Journal of Neurology, Neurosurgery and Psychiatry 2013 84 1186 1191 10.1136/jnnp-2012-304740 2-s2.0-84876941972
39. Murri M., Luque-Ramírez M., Insenser M., Ojeda-Ojeda M., Escobar-Morreale H. F., Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Human Reproduction Update 2013 19 3 268 288 10.1093/humupd/dms059 2-s2.0-84876401185
40. Kalyanaraman B., Teaching the basics of redox biology to medical and graduate students: oxidants, antioxidants and disease mechanisms. Redox Biology 2013 1 1 244 257 10.1016/j.redox.2013.01.014 2-s2.0-84878776025
41. Refsum H., Smith A. D., Ueland P. M., Nexo E., Clarke R., McPartlin J., Johnston C., Engbaek F., Schneede J., McPartlin C., Scott J. M., Facts and recommendations about total homocysteine determinations: an expert opinion. Clinical Chemistry 2004 50 1 3 32 10.1373/clinchem.2003.021634 2-s2.0-9144225352 (Pubitemid 38125696)
42. Bamonti F., Moscato G. A., Novembrino C., Gregori D., Novi C., De Giuseppe R., Galli C., Uva V., Lonati S., Maiavacca R., Determination of serum holotranscobalamin concentrations with the AxSYM active B12 assay: cut-off point evaluation in the clinical laboratory. Clinical Chemistry and Laboratory Medicine 2010 48 2 249 253 10.1515/CCLM.2010.032 2-s2.0-76649114666
43. Jacob K. D., Hooten N. N., Trzeciak A. R., Evans M. K., Markers of oxidant stress that are clinically relevant in aging and age-related disease. Mechanisms of Ageing and Development 2013 134 3-4 139 157 10.1016/j.mad.2013.02. 008 2-s2.0-84875082255
44. Aoyama K., Nakaki T., Impaired glutathione synthesis in neurodegeneration. International Journal of Molecular Sciences 2013 14 21021 21044
45. Rossi R., Dalle-Donne I., Milzani A., Giustarini D., Oxidized forms of glutathione in peripheral blood as biomarkers of oxidative stress. Clinical Chemistry 2006 52 7 1406 1414 10.1373/clinchem.2006.067793 2-s2.0-33745464371 (Pubitemid 43956034)
46. Sharma S. S., Dietz K. J., The relationship between metal toxicity and cellular redox imbalance. Trends in Plant Science 2009 14 1 43 50 10.1016/j.tplants.2008.10.007 2-s2.0-58149510121
47. Liu J., Qu W., Kadiiska M. B., Role of oxidative stress in cadmium toxicity and carcinogenesis. Toxicology and Applied Pharmacology 2009 238 3 209 214 10.1016/j.taap.2009.01.029 2-s2.0-67649641505
48. Ariu L. N. C., Morace G., Velio P., Campise M., Ciani A., Bamonti F., Total Antioxidant Capacity (TAC) assay can be used as an environment toxicity index. Clinical Chemistry 2006 A179